Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy-Reference-Cited by-同舟云学术

Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy

Published:2020-02-25 Issue:5 Volume:23 Page:1210-1216
ISSN:1368-5538
Container-title:The Aging Male
language:en
Short-container-title:The Aging Male

Author:

Kato Yuki¹,Shigehara Kazuyoshi¹,Kawaguchi Shohei¹,Izumi Kouji¹,Kadono Yoshifumi¹,Mizokami Atsushi¹

Affiliation:

1. Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan

Publisher

Informa UK Limited

Subject

Geriatrics and Gerontology

Link

https://www.tandfonline.com/doi/pdf/10.1080/13685538.2020.1731450

Reference37 articles.

1. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

2. High-dose-rate brachytherapy for large prostate volumes (≥50cc)—Uncompromised dosimetric coverage and acceptable toxicity

3. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

4. Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

5. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone Recovery after Androgen Deprivation Therapy in Prostate Cancer: Building a Predictive Model;The World Journal of Men's Health;2023

2. Pituitary-testis axis dysfunction following adjuvant androgen deprivation therapy;Endocrine-Related Cancer;2023-01-01

3. Relugolix, an oral gonadotropin-releasing hormone antagonist for the treatment of prostate cancer;Future Oncology;2021-11